| 发明名称 |
SUSTAINED RELEASE TABLET FOR ORAL USE |
| 摘要 |
<p>(Object) An oral sustained-release tablet is provided, which does not cause initial rapid increases in the bloodlevels of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide (KRP-197) and can maintain constant the blood levels. (Solving means) An oral sustained-release tablet comprises a pharmaceutical composition and a gel-forming material, the pharmaceutical composition containing KRP-197 as an active ingredient.</p> |
| 申请公布号 |
EP1652522(A1) |
申请公布日期 |
2006.05.03 |
| 申请号 |
EP20040748200 |
申请日期 |
2004.08.03 |
| 申请人 |
KYORIN PHARMACEUTICAL CO., LTD.;ONO PHARMACEUTICAL CO., LTD. |
发明人 |
HOSHINO, RYOUICHI;NAKASHIMA, KATASHI;KAZAMA, KAZUO |
| 分类号 |
A61K9/20;A61K9/22;A61K31/4174;A61K47/38;A61P13/00;A61P43/00;C07D233/61;(IPC1-7):A61K31/417 |
主分类号 |
A61K9/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
